Ranbaxy develops cheaper malaria drug

08/19/2004 | NYTimes.com

India's Ranbaxy Laboratories said its new anti-malarial drug costs less but works as well as the current drug being used, artemisinin. The chief executive of Medicines for Malaria Venture said the new medicine "could be the biggest breakthrough in malaria treatment of our generation."

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX